Rabin Medical Center
Renal function improves in pediatric liver transplant by switch in monitoring
Published in Law and Health Weekly, January 12th, 2004
According to recent research from Israel, "in adult liver transplant recipients, 2-h post-Neoral (C2) dose monitoring is associated with a lower incidence and severity of acute cellular rejection and improved renal function than C0 (trough level) monitoring.
"This study examined whether switching from C0 to C2 monitoring during maintenance also improves renal function in pediatric liver transplant recipients. Three boys aged 11-16 yr with stable graft function at 6-50 mo after liver transplantation were switched from...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Array BioPharma
Oncology deal signed for development of orally active MEK inhibitor - Matritech
Patricia Randall becomes VP and general counsel of cancer diagnostics company - BioVisioN AG
Peptidomics company names new chief scientific officer - Birmingham Heartlands Hospital
A new line probe assay identifies hepatitis B virus precore variants in sera - Bloomberg School of Public Health
Children get better care with developmental specialists on physician team - Boston Biomedica, Inc.
Diagnostic kit gets FDA approval - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
